Best Myeloma hematologist-oncologists in Spain: TOP 6 doctors

• Dr. Jaume Mora Graupera specializes in Myeloma treatment.
• He employs chemotherapy, stem cell transplants, and targeted therapy.
• Trained in the USA at Weill Cornell Medicine and Memorial Sloan Kettering.
• Directs Hematology Oncology Department at Sant Joan De Déu in Barcelona.
• Member of the American Society of Clinical Oncology, representing high professionalism.
• Offers remote consultations for Myeloma patients, enhancing accessibility.
• Fluent in English and Spanish, facilitating communication with diverse patients.

• Specializes in advanced Myeloma treatment methods, ensuring personalized care.
• Utilizes stem cell transplantation, targeted therapy, and radiation to combat Myeloma.
• International experience in Europe and America enhances diverse treatment approaches.
• Holds critical certifications in Hematology and Pediatric Hemato-Oncology.
• Member of prestigious medical societies, staying abreast of Myeloma research.
• Offers online consultations for global patient accessibility.
• Conversant in numerous languages, facilitating communication with a wide patient base.

• Specializes in Myeloma treatment, utilizing advanced methods.
• Myeloma therapies include stem cell transplant, chemotherapy, and targeted therapy.
• International practice in countries with leading cancer research.
• Certified Hematologist, expertise in bone marrow transplantation.
• Member of professional hematological societies, ensuring up-to-date practices.
• Offers online consultations for Myeloma patients worldwide.
• Speaks multiple languages, enhancing patient comfort and understanding.

Dr. Jaime Pérez de Oteyza is a Spanish hematologist and heads the Hematology and Hematology Oncology Department at HM Hospitales Group. He is an expert in diagnostics and treatment of hematology conditions and hematopoietic stem cell transplant, and has taken part in the first bone marrow transplant in Spain. He holds a degree in general medicine from CEU San Pablo University, has trained in lymphomas pathology at Kiel University, and has a specialty in hematology and hemotherapy from the University of Alcalá. He has won numerous awards for his scientific research and has published over 40 papers on his studies. He is a member of the Spanish Hematology and Hemotherapy Society.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.